- 1 Indian Army Releases First UAS & Loitering Munitions Roadmap
- 2 India Advances Defence Capabilities with Key Procurement Agreements
- 3 Indian Navy Commissions INS Taragiri Stealth Frigate
- 4 Indian Navy Inducts ‘Dunagiri’ Stealth Frigate
- 5 ‘Malwan’ Anti-Submarine Warfare Shallow Water Craft
- 6 Indian Navy Inducts ‘Sanshodhak’
- 7 India’s Prototype Fast Breeder Reactor (PFBR) Achieves Criticality
- 8 India Demonstrates 1,000-km Quantum Communication Network
- 9 India Lays Foundation for First Advanced 3D Chip Packaging Unit in Odisha
- 10 IVRI Produces Indigenous Sahiwal Calves Using IVF Technology
- 11 Artemis II Mission Completes Historic Lunar Fly-by
- 12 Mission MITRA Launched to Study Human Factors for Space Missions
- 13 IOC Mandates SRY Gene Screening for Female Athletes
- 14 India Commissions Third SSBN ‘Aridhaman’
- 15 First NGOPV ‘Shachi’ Launched in Goa
- 16 Dengue Vaccine TAK-003 Cleared by DCGI
- 17 Memristor
- 18 Digital Humans
Keytruda
Recently, concerns have emerged in India over a black market for Keytruda, driven by high costs and limited access.
- Keytruda is the brand name of pembrolizumab, an advanced cancer immunotherapy drug.
- Developed by Merck & Co., it is among the world’s top-selling cancer drugs.
- It belongs to a class called checkpoint inhibitors, which enhance immune response against cancer.
- Works by blocking PD-1 receptors on T-cells, preventing cancer cells from evading immune detection.
- Enables the body’s immune system to identify and destroy cancer cells more effectively.
- Used to treat cancers like lung, melanoma, cervical, kidney, and certain breast cancers.
- Unlike chemotherapy, ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 India Approves First Dengue Vaccine
- 2 NeoSep1 Trial for Neonatal Sepsis
- 3 WHO Lists First Ebola BDBV Diagnostic Test
- 4 Mission Drishti Encounters Anomaly After Solar Storm
- 5 ISRO Conducts Gaganyaan IMAT-05 Test
- 6 India Launches Once-Weekly Basal Insulin
- 7 White Rabbit-Based Indian Standard Time Distribution Network
- 8 World's Largest Synchronized Spintronic Network Demonstrated
- 9 CeNS Develops Ultra-Sensitive Ammonia Sensor
- 10 MOF Material Removes Tritium Efficiently
